Skip to main content
PMC home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 1999 Jan;80(1):F21–F25. doi: 10.1136/fn.80.1.f21

Raised concentrations of aldehyde lipid peroxidation products in premature infants with chronic lung disease

T Ogihara, K Hirano, T Morinobu, H Kim, M Hiroi, H Ogihara, H Tamai
PMCID: PMC1720880  PMID: 10325806

Abstract

AIM—To indicate the extent of lipid peroxidation induced by oxidative stress, by measuring aldehyde end products in biological samples.
METHODS—A highly specific gas chromatography and mass spectrometry (GC/MS) method was used to measure plasma concentrations of aliphatic aldehydes within the first week of life in 13 premature infants who subsequently developed chronic lung disease (CLD) and 11 infants without CLD (non-CLD). The oxime-tert-butyldimethylsilyl derivatives of aldehydes were analysed using 2,2,6,6-d4-cyclohexanone as the internal standard.
RESULTS—All of the aldehydes measured were raised in those infants with CLD compared with non-CLD infants. Plasma concentrations of heptanal, 2-nonenal, and 4-hydroxynonenal (HNE) were significantly increased in CLD infants on the day of birth, while the differences in all aldehydes between the two groups were not significant at 4-6 days of age. Logistic regression analysis showed that the increase in these three aldehydes within the first 24 hours of life independently showed significant associations with the development of CLD. In particular, an HNE concentration of ⩾ 200 nM on day 0 was the best predictor for the early detection of CLD (odds ratio = 32.0), followed by a 2-nonenal concentration of ⩾ 150nM (odds ratio = 16.0).
CONCLUSIONS—These findings suggest that lipid peroxidation may have a role in the pathogenesis of neonatal CLD.



Full Text

The Full Text of this article is available as a PDF (137.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blasig I. E., Grune T., Schönheit K., Rohde E., Jakstadt M., Haseloff R. F., Siems W. G. 4-Hydroxynonenal, a novel indicator of lipid peroxidation for reperfusion injury of the myocardium. Am J Physiol. 1995 Jul;269(1 Pt 2):H14–H22. doi: 10.1152/ajpheart.1995.269.1.H14. [DOI] [PubMed] [Google Scholar]
  2. Esterbauer H., Schaur R. J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med. 1991;11(1):81–128. doi: 10.1016/0891-5849(91)90192-6. [DOI] [PubMed] [Google Scholar]
  3. Frankel E. N., Hu M. L., Tappel A. L. Rapid headspace gas chromatography of hexanal as a measure of lipid peroxidation in biological samples. Lipids. 1989 Nov;24(11):976–981. doi: 10.1007/BF02544544. [DOI] [PubMed] [Google Scholar]
  4. Gutteridge J. M. Aspects to consider when detecting and measuring lipid peroxidation. Free Radic Res Commun. 1986;1(3):173–184. doi: 10.3109/10715768609083149. [DOI] [PubMed] [Google Scholar]
  5. Halliwell B., Chirico S. Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr. 1993 May;57(5 Suppl):715S–725S. doi: 10.1093/ajcn/57.5.715S. [DOI] [PubMed] [Google Scholar]
  6. Holley A. E., Walker M. K., Cheeseman K. H., Slater T. F. Measurement of n-alkanals and hydroxyalkenals in biological samples. Free Radic Biol Med. 1993 Sep;15(3):281–289. doi: 10.1016/0891-5849(93)90075-6. [DOI] [PubMed] [Google Scholar]
  7. Inder T. E., Graham P., Sanderson K., Taylor B. J. Lipid peroxidation as a measure of oxygen free radical damage in the very low birthweight infant. Arch Dis Child Fetal Neonatal Ed. 1994 Mar;70(2):F107–F111. doi: 10.1136/fn.70.2.f107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kotecha S., Wangoo A., Silverman M., Shaw R. J. Increase in the concentration of transforming growth factor beta-1 in bronchoalveolar lavage fluid before development of chronic lung disease of prematurity. J Pediatr. 1996 Apr;128(4):464–469. doi: 10.1016/s0022-3476(96)70355-4. [DOI] [PubMed] [Google Scholar]
  9. MICHAUELSSON M., NOSSLIN B., SJOELIN S. PLASMA BILIRUBIN DETERMINATION IN THE NEWBORN INFANT. A METHODOLOGICAL STUDY WITH SPECIAL REFERENCE TO THE INFLUENCE OF HEMOLYSIS. Pediatrics. 1965 Jun;35:925–931. [PubMed] [Google Scholar]
  10. McCarthy K., Bhogal M., Nardi M., Hart D. Pathogenic factors in bronchopulmonary dysplasia. Pediatr Res. 1984 May;18(5):483–488. doi: 10.1203/00006450-198405000-00018. [DOI] [PubMed] [Google Scholar]
  11. Moison R. M., de Beaufort A. J., Haasnoot A. A., Dubbelman T. M., van Zoeren-Grobben D., Berger H. M. Uric acid and ascorbic acid redox ratios in plasma and tracheal aspirate of preterm babies with acute and chronic lung disease. Free Radic Biol Med. 1997;23(2):226–234. doi: 10.1016/s0891-5849(97)00033-6. [DOI] [PubMed] [Google Scholar]
  12. Niki E. Antioxidants in relation to lipid peroxidation. Chem Phys Lipids. 1987 Jul-Sep;44(2-4):227–253. doi: 10.1016/0009-3084(87)90052-1. [DOI] [PubMed] [Google Scholar]
  13. Norsten-Hög C., Cronholm T. Analysis of aldehydic lipid peroxidation products in rat liver and hepatocytes by gas chromatography and mass spectrometry of the oxime-tert-butyldimethylsilyl derivatives. Anal Biochem. 1990 Aug 15;189(1):131–137. doi: 10.1016/0003-2697(90)90058-h. [DOI] [PubMed] [Google Scholar]
  14. Northway W. H., Jr Bronchopulmonary dysplasia: then and now. Arch Dis Child. 1990 Oct;65(10 Spec No):1076–1081. doi: 10.1136/adc.65.10_spec_no.1076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ogawa Y., Fujimura M., Goto A., Kawano T., Kondo T., Nakae N., Nishida A., Ohno T., Takeuchi Y., Togari H. Epidemiology of neonatal chronic lung disease in Japan. Acta Paediatr Jpn. 1992 Dec;34(6):663–667. doi: 10.1111/j.1442-200x.1992.tb01028.x. [DOI] [PubMed] [Google Scholar]
  16. Ogden B. E., Murphy S. A., Saunders G. C., Pathak D., Johnson J. D. Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. Am Rev Respir Dis. 1984 Nov;130(5):817–821. doi: 10.1164/arrd.1984.130.5.817. [DOI] [PubMed] [Google Scholar]
  17. Ogihara T., Kim H. S., Hirano K., Imanishi M., Ogihara H., Tamai H., Okamoto R., Mino M. Oxidation products of uric acid and ascorbic acid in preterm infants with chronic lung disease. Biol Neonate. 1998;73(1):24–33. doi: 10.1159/000013956. [DOI] [PubMed] [Google Scholar]
  18. Ogihara T., Okamoto R., Kim H. S., Nagai A., Morinobu T., Moji H., Kamegai H., Hirano K., Ogihara H., Tamai H. New evidence for the involvement of oxygen radicals in triggering neonatal chronic lung disease. Pediatr Res. 1996 Jan;39(1):117–119. doi: 10.1203/00006450-199601000-00017. [DOI] [PubMed] [Google Scholar]
  19. Pattle R. E., Kratzing C. C., Parkinson C. E., Graves L., Robertson R. D., Robards G. J., Currie J. O., Parsons J. H., Sutherland P. D. Maturity of fetal lungs tested by production of stable microbubbles in amniotic fluid. Br J Obstet Gynaecol. 1979 Aug;86(8):615–622. doi: 10.1111/j.1471-0528.1979.tb10823.x. [DOI] [PubMed] [Google Scholar]
  20. Pitkänen O. M., Hallman M., Andersson S. M. Correlation of free oxygen radical-induced lipid peroxidation with outcome in very low birth weight infants. J Pediatr. 1990 May;116(5):760–764. doi: 10.1016/s0022-3476(05)82668-x. [DOI] [PubMed] [Google Scholar]
  21. Poli G., Parola M. Oxidative damage and fibrogenesis. Free Radic Biol Med. 1997;22(1-2):287–305. doi: 10.1016/s0891-5849(96)00327-9. [DOI] [PubMed] [Google Scholar]
  22. Saugstad O. D. Oxygen toxicity in the neonatal period. Acta Paediatr Scand. 1990 Oct;79(10):881–892. doi: 10.1111/j.1651-2227.1990.tb11348.x. [DOI] [PubMed] [Google Scholar]
  23. Schmidt H., Grune T., Müller R., Siems W. G., Wauer R. R. Increased levels of lipid peroxidation products malondialdehyde and 4-hydroxynonenal after perinatal hypoxia. Pediatr Res. 1996 Jul;40(1):15–20. doi: 10.1203/00006450-199607000-00003. [DOI] [PubMed] [Google Scholar]
  24. Strange R. C., Cotton W., Fryer A. A., Jones P., Bell J., Hume R. Lipid peroxidation and expression of copper-zinc and manganese superoxide dismutase in lungs of premature infants with hyaline membrane disease and bronchopulmonary dysplasia. J Lab Clin Med. 1990 Nov;116(5):666–673. [PubMed] [Google Scholar]
  25. Tamai H., Manago M., Yokota K., Kitagawa M., Mino M. Determination of alpha-tocopherol in buccal mucosal cells using an electrochemical detector. Int J Vitam Nutr Res. 1988;58(2):202–207. [PubMed] [Google Scholar]
  26. Yazdanpanah M., Luo X., Lau R., Greenberg M., Fisher L. J., Lehotay D. C. Cytotoxic aldehydes as possible markers for childhood cancer. Free Radic Biol Med. 1997;23(6):870–878. doi: 10.1016/s0891-5849(97)00070-1. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood. Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES